Thus, activation of NF‐κB signalling is associated with cancer development, metastasis and chemical resistance, and abnormal constitutive activation of NF‐κB signalling has been demonstrated in human cancers, including lung, prostate, breast and bladder cancers. This evidence concerns the gene NFKB1 and cancer.